• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三唑类化合物的合成方法及抗真菌活性研究进展。

Advances in synthetic approach to and antifungal activity of triazoles.

机构信息

Department of Pharmaceutical Technology, Meerut Institute of Engineering & Technology, Meerut, U. P., India, Pin-250005.

出版信息

Beilstein J Org Chem. 2011;7:668-77. doi: 10.3762/bjoc.7.79. Epub 2011 May 25.

DOI:10.3762/bjoc.7.79
PMID:21804864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3135122/
Abstract

Several five membered ring systems, e.g., triazole, oxadiazole dithiazole and thiadiazole with three heteroatoms at symmetrical or asymmetrical positions have been studied because of their interesting pharmacological properties. In this article our emphasis is on synthetic development and pharmacological activity of the triazole moiety which exhibit a broad spectrum of pharmacological activity such as antifungal, antibacterial, anti-inflammatory and anticancer etc. Triazoles have increased our ability to treat many fungal infections, for example, candidiasis, cryptococcal meningitis, aspergillosis etc. However, mortality due to these infections even with antifungal therapy is still unacceptably high. Therefore, the development of new antifungal agents targeting specific fungal structures or functions is being actively pursued. Rapid developments in molecular mycology have led to a concentrated search for more target antifungals. Although we are entering a new era of antifungal therapy in which we will continue to be challenged by systemic fungal diseases, the options for treatment will have greatly expanded.

摘要

一些五元环系统,例如三唑、恶二唑、二硫代恶唑和噻二唑,由于其具有有趣的药理学性质,因此在对称或不对称位置上具有三个杂原子。本文重点介绍了三唑部分的合成发展和药理学活性,该部分具有广泛的药理学活性,如抗真菌、抗菌、抗炎和抗癌等。三唑类化合物提高了我们治疗许多真菌感染的能力,例如念珠菌病、隐球菌性脑膜炎、曲霉菌病等。然而,即使进行抗真菌治疗,这些感染的死亡率仍然高得令人无法接受。因此,正在积极开发针对特定真菌结构或功能的新型抗真菌药物。分子真菌学的快速发展导致了对更多靶向抗真菌药物的集中研究。尽管我们正在进入一个新的抗真菌治疗时代,我们将继续受到系统性真菌感染的挑战,但治疗选择将大大扩大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/0fba7d7c2309/Beilstein_J_Org_Chem-07-668-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/a6379ffc8af6/Beilstein_J_Org_Chem-07-668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/da827fc4fcc2/Beilstein_J_Org_Chem-07-668-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/0271184e943e/Beilstein_J_Org_Chem-07-668-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/fca9f53d7f92/Beilstein_J_Org_Chem-07-668-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/11b3b39583eb/Beilstein_J_Org_Chem-07-668-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/e64ab4e30bb2/Beilstein_J_Org_Chem-07-668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/a676e432c8c6/Beilstein_J_Org_Chem-07-668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/ec427ea17ba4/Beilstein_J_Org_Chem-07-668-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/fd9deef67458/Beilstein_J_Org_Chem-07-668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/1846f09ec5c3/Beilstein_J_Org_Chem-07-668-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/efb7bbfc1274/Beilstein_J_Org_Chem-07-668-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/a58e54320eca/Beilstein_J_Org_Chem-07-668-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/27fa6486eced/Beilstein_J_Org_Chem-07-668-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/00ee1d6b8c35/Beilstein_J_Org_Chem-07-668-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/8e55edeea95b/Beilstein_J_Org_Chem-07-668-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/0fba7d7c2309/Beilstein_J_Org_Chem-07-668-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/a6379ffc8af6/Beilstein_J_Org_Chem-07-668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/da827fc4fcc2/Beilstein_J_Org_Chem-07-668-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/0271184e943e/Beilstein_J_Org_Chem-07-668-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/fca9f53d7f92/Beilstein_J_Org_Chem-07-668-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/11b3b39583eb/Beilstein_J_Org_Chem-07-668-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/e64ab4e30bb2/Beilstein_J_Org_Chem-07-668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/a676e432c8c6/Beilstein_J_Org_Chem-07-668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/ec427ea17ba4/Beilstein_J_Org_Chem-07-668-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/fd9deef67458/Beilstein_J_Org_Chem-07-668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/1846f09ec5c3/Beilstein_J_Org_Chem-07-668-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/efb7bbfc1274/Beilstein_J_Org_Chem-07-668-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/a58e54320eca/Beilstein_J_Org_Chem-07-668-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/27fa6486eced/Beilstein_J_Org_Chem-07-668-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/00ee1d6b8c35/Beilstein_J_Org_Chem-07-668-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/8e55edeea95b/Beilstein_J_Org_Chem-07-668-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29b/3135122/0fba7d7c2309/Beilstein_J_Org_Chem-07-668-g013.jpg

相似文献

1
Advances in synthetic approach to and antifungal activity of triazoles.三唑类化合物的合成方法及抗真菌活性研究进展。
Beilstein J Org Chem. 2011;7:668-77. doi: 10.3762/bjoc.7.79. Epub 2011 May 25.
2
The future of antifungal therapy.
Clin Infect Dis. 1996 May;22 Suppl 2:S166-78. doi: 10.1093/clinids/22.supplement_2.s166.
3
The search for new triazole antifungal agents.新型三唑类抗真菌药物的研究
Curr Opin Chem Biol. 1997 Aug;1(2):176-82. doi: 10.1016/s1367-5931(97)80007-5.
4
Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.艾沙康唑:一种新型三唑类抗真菌药物的药理学、药效学及当前临床经验
Pharmacotherapy. 2015 Nov;35(11):1037-51. doi: 10.1002/phar.1652. Epub 2015 Nov 2.
5
Posaconazole: a new broad-spectrum antifungal agent.泊沙康唑:一种新型广谱抗真菌药物。
Expert Opin Pharmacother. 2007 Jun;8(8):1167-78. doi: 10.1517/14656566.8.8.1167.
6
Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.脂质体两性霉素B:关于其在发热性中性粒细胞减少症经验性治疗及侵袭性真菌感染治疗中应用的综述
Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010.
7
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.新型三唑类抗真菌药物:药理学、抗菌谱、临床疗效及局限性
Expert Opin Investig Drugs. 2006 Jun;15(6):579-602. doi: 10.1517/13543784.15.6.579.
8
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.伏立康唑:一种用于治疗严重和侵袭性真菌感染的广谱三唑类药物。
Future Microbiol. 2006 Dec;1(4):365-85. doi: 10.2217/17460913.1.4.365.
9
New antifungal agents.新型抗真菌药物。
Dermatol Clin. 2003 Jul;21(3):565-76. doi: 10.1016/s0733-8635(03)00024-x.
10
Recent advances bioactive 1,2,4-triazole-3-thiones.生物活性1,2,4-三唑-3-硫酮的最新进展。 不过你提供的原文“Recent advances bioactive 1,2,4-triazole-3-thiones.”表述不太完整准确,正常应该是“Recent advances in bioactive 1,2,4-triazole-3-thiones” 。
Eur J Med Chem. 2015 Jun 5;97:830-70. doi: 10.1016/j.ejmech.2014.11.033. Epub 2014 Nov 26.

引用本文的文献

1
Pharmacological Evaluation of Bioisosterically Replaced and Triazole- Tethered Derivatives for Anticancer Therapy.用于抗癌治疗的生物电子等排体取代及三唑连接衍生物的药理学评价
Med Chem. 2025;21(4):264-293. doi: 10.2174/0115734064320533240903062533.
2
Novel Coumarin-Nucleobase Hybrids with Potential Anticancer Activity: Synthesis, In Vitro Cell-Based Evaluation, and Molecular Docking.具有潜在抗癌活性的新型香豆素-核碱基杂化物:合成、基于细胞的体外评估及分子对接
Pharmaceuticals (Basel). 2024 Jul 17;17(7):956. doi: 10.3390/ph17070956.
3
Stereoselective Asymmetric Syntheses of Molecules with a 4,5-Dihydro-1-[1,2,4]-Triazoline Core Possessing an Acetylated Carbohydrate Appendage: Crystal Structure, Spectroscopy, and Pharmacology.

本文引用的文献

1
Cationic heteroleptic cyclometalated iridium(III) complexes containing phenyl-triazole and triazole-pyridine clicked ligands.含苯并三唑和三唑吡啶点击配体的阳离子杂环金属铱(III)配合物。
Molecules. 2010 Mar 23;15(3):2039-59. doi: 10.3390/molecules15032039.
2
1,1'-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligands.1,1'-二取代二茂铁作为单价和二价多巴胺受体配体中的分子铰链。
J Med Chem. 2009 Nov 12;52(21):6860-70. doi: 10.1021/jm901120h.
3
'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.
具有乙酰化碳水化合物侧链的 4,5-二氢-1-[1,2,4]-三唑啉核心分子的立体选择性不对称合成:晶体结构、光谱和药理学。
Molecules. 2024 Jun 14;29(12):2839. doi: 10.3390/molecules29122839.
4
Evaluation of phytoconstituents in marigold effluent for their antifungal activity against plant pathogens.评估万寿菊废水的植物成分对植物病原体的抗真菌活性。
Front Fungal Biol. 2024 Apr 4;5:1345543. doi: 10.3389/ffunb.2024.1345543. eCollection 2024.
5
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Species.与致病物种中抗真菌耐药性相关的分子机制。
Cells. 2023 Nov 19;12(22):2655. doi: 10.3390/cells12222655.
6
Developmental Neurotoxicity of Difenoconazole in Zebrafish Embryos.苯醚甲环唑对斑马鱼胚胎的发育神经毒性
Toxics. 2023 Apr 8;11(4):353. doi: 10.3390/toxics11040353.
7
Regioselective Synthesis of 5-Trifluoromethyl 1,2,4-Triazoles via [3 + 2]-Cycloaddition of Nitrile Imines with CFCN.通过腈亚胺与 CFCN 的 [3 + 2]-环加成反应区域选择性合成 5-三氟甲基 1,2,4-三唑
Molecules. 2022 Oct 4;27(19):6568. doi: 10.3390/molecules27196568.
8
Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A.发现一类新型三唑基乙酰转移酶 KAT2A 抑制剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1987-1994. doi: 10.1080/14756366.2022.2097447.
9
active organometallic-containing antimycotic agents.活性有机金属抗真菌剂
RSC Chem Biol. 2021 Jul 8;2(4):1263-1273. doi: 10.1039/d1cb00123j. eCollection 2021 Aug 5.
10
A Review on Antifungal Efficiency of Plant Extracts Entrenched Polysaccharide-Based Nanohydrogels.植物提取物强化多糖基纳米水凝胶的抗真菌效率研究综述。
Nutrients. 2021 Jun 15;13(6):2055. doi: 10.3390/nu13062055.
具有5-HT(1A)受体药效基团并产生D(2)受体活性的“咔哒”D(1)受体激动剂。
Bioorg Med Chem. 2009 Jul 15;17(14):4873-80. doi: 10.1016/j.bmc.2009.06.019. Epub 2009 Jun 16.
4
Peptide cyclization and cyclodimerization by Cu(I)-mediated azide-alkyne cycloaddition.通过铜(I)介导的叠氮化物-炔烃环加成实现肽的环化和环二聚化。
J Org Chem. 2009 Apr 17;74(8):2964-74. doi: 10.1021/jo802097m.
5
Synthesis and antimicrobial activities of some new triazolothiadiazoles bearing 4-methylthiobenzyl moiety.一些带有4-甲硫基苄基部分的新型三唑并噻二唑的合成与抗菌活性
Eur J Med Chem. 2009 Feb;44(2):551-7. doi: 10.1016/j.ejmech.2008.03.025. Epub 2008 Apr 4.
6
Synthesis and antimicrobial activity of beta-lactam-bile acid conjugates linked via triazole.通过三唑连接的β-内酰胺-胆汁酸共轭物的合成与抗菌活性
Bioorg Med Chem Lett. 2008 Mar 15;18(6):2043-7. doi: 10.1016/j.bmcl.2008.01.102. Epub 2008 Jan 31.
7
Sulfonamide-1,2,4-triazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies.作为抗真菌和抗菌剂的磺酰胺-1,2,4-三唑衍生物:合成、生物学评价、亲脂性及构象研究
Bioorg Med Chem. 2008 Feb 1;16(3):1150-61. doi: 10.1016/j.bmc.2007.10.082. Epub 2007 Nov 28.
8
Efficient synthesis and in vitro cytostatic activity of 4-substituted triazolyl-nucleosides.4-取代三唑基核苷的高效合成及其体外细胞抑制活性
Bioorg Med Chem Lett. 2007 Dec 1;17(23):6656-9. doi: 10.1016/j.bmcl.2007.08.077. Epub 2007 Sep 29.
9
Dual action-based approaches to antibacterial agents.基于双重作用的抗菌剂方法。
Curr Med Chem. 2007;14(13):1459-77. doi: 10.2174/092986707780831168.
10
Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.某些稠合1,2,4-三唑衍生物的合成、亲脂性测定、抗癌及抗菌性能
Eur J Med Chem. 2008 Feb;43(2):404-19. doi: 10.1016/j.ejmech.2007.03.033. Epub 2007 Apr 14.